These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 24997180)
1. The role of social deprivation in severe neovascular age-related macular degeneration. Sharma HE; Mathewson PA; Lane M; Shah P; Glover N; Palmer H; Haque MS; Denniston AK; Tsaloumas MD Br J Ophthalmol; 2014 Dec; 98(12):1625-8. PubMed ID: 24997180 [TBL] [Abstract][Full Text] [Related]
2. The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration. Finger RP; Guymer RH; Gillies MC; Keeffe JE Ophthalmology; 2014 Jun; 121(6):1246-51. PubMed ID: 24518613 [TBL] [Abstract][Full Text] [Related]
3. Tracing the natural course of visual acuity and quality of life in neovascular age-related macular degeneration: a systematic review and quality of life study. Elshout M; Webers CA; van der Reis MI; de Jong-Hesse Y; Schouten JS BMC Ophthalmol; 2017 Jul; 17(1):120. PubMed ID: 28693519 [TBL] [Abstract][Full Text] [Related]
4. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY. Lee H; Ji B; Chung H; Kim HC Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214 [TBL] [Abstract][Full Text] [Related]
5. Recovery of the neurosensory retina after macular translocation surgery is independent of preoperative macular sensitivity in neovascular age-related macular degeneration. Mettu PS; Sarin N; Stinnett SS; Toth CA Retina; 2011 Sep; 31(8):1637-49. PubMed ID: 21775925 [TBL] [Abstract][Full Text] [Related]
6. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089 [TBL] [Abstract][Full Text] [Related]
7. Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK. Keenan TD; Kelly SP; Sallam A; Mohamed Q; Tufail A; Johnston RL Br J Ophthalmol; 2013 Sep; 97(9):1168-72. PubMed ID: 23813420 [TBL] [Abstract][Full Text] [Related]
12. Neovascular age-related macular degeneration associated with no light perception. Brown GC; Basha MM; Brown MM Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):229-34. PubMed ID: 25707049 [TBL] [Abstract][Full Text] [Related]
13. Visual outcomes in relation to time to treatment in neovascular age-related macular degeneration. Rasmussen A; Brandi S; Fuchs J; Hansen LH; Lund-Andersen H; Sander B; Larsen M Acta Ophthalmol; 2015 Nov; 93(7):616-20. PubMed ID: 26073051 [TBL] [Abstract][Full Text] [Related]
14. Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results. Dunavoelgyi R; Sacu S; Eibenberger K; Palkovits S; Leydolt C; Pruente C; Schmidt-Erfurth U Retina; 2012 Sep; 32(8):1471-9. PubMed ID: 22414958 [TBL] [Abstract][Full Text] [Related]
15. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results. Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967 [TBL] [Abstract][Full Text] [Related]
16. Long-Term Results of Full Macular Translocation for Choroidal Neovascularization in Age-Related Macular Degeneration. van Romunde SH; Polito A; Bertazzi L; Guerriero M; Pertile G Ophthalmology; 2015 Jul; 122(7):1366-74. PubMed ID: 25881514 [TBL] [Abstract][Full Text] [Related]
17. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Dong LM; Childs AL; Mangione CM; Bass EB; Bressler NM; Hawkins BS; Marsh MJ; Miskala P; Jaffee HA; McCaffrey LA; Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287 [TBL] [Abstract][Full Text] [Related]
18. Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting. Boulanger-Scemama E; Querques G; About F; Puche N; Srour M; Mane V; Massamba N; Canoui-Poitrine F; Souied EH J Fr Ophtalmol; 2015 Sep; 38(7):620-7. PubMed ID: 25913443 [TBL] [Abstract][Full Text] [Related]
19. Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab. Bressler NM; Chang TS; Varma R; Suñer I; Lee P; Dolan CM; Ward J; Ianchulev T; Fine J Ophthalmology; 2013 Jan; 120(1):160-8. PubMed ID: 23009891 [TBL] [Abstract][Full Text] [Related]